GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus.

CONCLUSION: The significant potency and appreciable safety of GLP-1 RAs manifested their potential as a logical approach for the management of type 2 diabetes. PMID: 31057118 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31057118?dopt=Abstract

Source: Current Diabetes Reviews - May 1, 2019 Category: Endocrinology Authors: Dahiya L, Kaur R, Kumar R, Kumar M, Palta K Tags: Curr Diabetes Rev Source Type: research